[HTML][HTML] A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker …
S Sjoqvist, K Otake - Biochemical and Biophysical Research …, 2022 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder which is
characterized by progressive degeneration of the motor system. Typically, the disease starts …
characterized by progressive degeneration of the motor system. Typically, the disease starts …
A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates
S Sjoqvist, K Otake - Biochemical and biophysical …, 2022 - pubmed.ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder which is
characterized by progressive degeneration of the motor system. Typically, the disease starts …
characterized by progressive degeneration of the motor system. Typically, the disease starts …
[PDF][PDF] A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker …
S Sjoqvist, K Otake - Biochemical and Biophysical Research …, 2022 - researchgate.net
abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder which is
characterized by progressive degeneration of the motor system. Typically, the disease starts …
characterized by progressive degeneration of the motor system. Typically, the disease starts …